TickerFacts.

Endonovo Therapeutics, Inc. (ENDV): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Not updated since 2022-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$2.62M
Year ended 2022-12-31
2013-12-31: -$2.42M2014-12-31: -$2.18M2015-12-31: -$2.55M2016-12-31: -$5.40M2017-12-31: -$4.59M2018-12-31: -$3.51M2019-12-31: -$3.16M2020-12-31: -$2.26M2021-12-31: -$1.58M2022-12-31: -$2.62M-$2.62M
2013-12-31 EBITDA (USD) 2022-12-31
Period endedEBITDAChange YoYSource filing
2022-12-31-$2.62Mn/m2023-04-17, From 2022-01-01
2021-12-31-$1.58Mn/m2023-04-17, From 2021-01-01
2020-12-31-$2.26Mn/m2022-04-14, From 2020-01-01
2019-12-31-$3.16Mn/m2021-04-13, From 2019-01-01
2018-12-31-$3.51Mn/m2020-05-04, From 2018-01-01
2017-12-31-$4.59Mn/m2019-04-15, From 2017-01-01
2016-12-31-$5.40Mn/m2018-04-06, From 2016-01-01
2015-12-31-$2.55Mn/m2017-04-17, From 2015-01-01
2014-12-31-$2.18Mn/m2016-05-17, From 2014-01-01
2013-12-31-$2.42Mn/a2015-06-15, From 2013-01-01